Concepedia
Statistics
Publications
5
Citations
73
H-Index
Active since
2019
Affiliations
Inserm(Current)
Université Paris-Est Créteil
Centre Hospitalier Universitaire Henri-Mondor
Assistance Publique – Hôpitaux de Paris
Centre International de Recherche en Infectiologie
Alizée Maarek is an author at Inserm specializing in immunotherapy, cancer immunotherapy, and pharmacology.
Publications per year
2019–2022
HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma
Estelle Bourbon, Pierre Sesques, Morgane Gossez et al. · Blood Advances · 2022 · 23 citations · Full text
Life Sciences, Hematology, Immunology +15
Venetoclax induces profound and sustained responses in patients with relapsed/refractory light‐chain amyloidosis
Hélène Pasquer, Karim Belhadj, Jehan Dupuis et al. · British Journal of Haematology · 2021 · 17 citations
Medicine, Pharmacology, Pharmacotherapy +15
Characteristics of T- and NK-cell Lymphomas After Renal Transplantation: A French National Multicentric Cohort Study
Thomas Barba, Emmanuel Bachy, Alizée Maarek et al. · Transplantation · 2021 · 12 citations
Medicine, Hematology, Pathology +15
Venetoclax induces sustained complete responses in refractory/relapsed patients with cardiac AL amyloidosis.
Fabien Le Bras, Jehan Dupuis, François Lemonnier et al. · Journal of Clinical Oncology · 2019 · 11 citations
Medicine, Pharmacology, Pharmacotherapy +13
Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment
Romain Gounot, Fabien Le Bras, Jehan Dupuis et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 10 citations
Life Sciences, Hematology, Immunology +9
1–5 of 5